This inventor holds 3 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2005-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2009
Introduction
Takanori Minami is an accomplished inventor hailing from Itano-gun, Japan. With a remarkable portfolio comprising three patents, he has been instrumental in advancing the field of medicinal compositions. His innovative work holds significant promise for enhancing drug efficacy and safety, contributing greatly to the pharmaceutical landscape.
Latest Patents
Minami's recent patents focus on the development of medicinal compositions that include a pharmacologically active substance, a drug absorbefacient, and either a taurine compound or a polyamine. His innovations emphasize the important role these components play in safeguarding the intestinal mucous membrane. The inclusion of a taurine compound is shown to suppress or prevent damage to this delicate tissue, while polyamines are recognized for their ability to enhance the absorbability of pharmacologically active substances. This innovative combination not only improves efficacy but also reduces the required dosage of drug absorbefacients, resulting in a safer therapeutic profile.
Career Highlights
Currently, Minami is affiliated with Otsuka Pharmaceutical Company, Limited, where he continues to delve into research that aims to optimize drug formulations. His work reflects a deep commitment to enhancing patient outcomes through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Minami has collaborated with talented colleagues, including Toshikiro Kimura and Kazutaka Higaki. Together, these researchers have pooled their expertise to push the boundaries of medicinal chemistry, fostering an environment of innovation and growth.
Conclusion
Takanori Minami stands out as a significant figure in the realm of pharmaceutical inventions. His dedication to developing advanced medicinal compositions highlights the integral role of innovation in healthcare. Through his contributions, he not only enhances the efficacy of treatments but also prioritizes patient safety, making him a valuable asset to the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile